» Articles » PMID: 37802041

The Need for an Intersectionality Framework in Precision Medicine Research

Overview
Journal Am J Hum Genet
Publisher Cell Press
Specialty Genetics
Date 2023 Oct 6
PMID 37802041
Authors
Affiliations
Soon will be listed here.
Abstract

Precision medicine research has seen growing efforts to increase participation of communities that have been historically underrepresented in biomedical research. Marginalized racial and ethnic communities have received particular attention, toward the goal of improving the generalizability of scientific knowledge and promoting health equity. Against this backdrop, research has highlighted three key issues that could impede the promise of precision medicine research: issues surrounding (dis)trust and representation, challenges in translational efforts to improve health outcomes, and the need for responsive community engagement. Existing efforts to address these challenges have predominantly centered on single-dimensional demographic criteria such as race, ethnicity, or sex, while overlooking how these and additional variables, such as disability, gender identity, and socioeconomic factors, can confound and jointly impact research participation. We argue that increasing cohort diversity and the responsiveness of precision medicine research studies to community needs requires an approach that transcends conventional boundaries and embraces a more nuanced, multi-layered, and intersectional framework for data collection, analyses, and implementation. We draw attention to gaps in existing work, highlight how overlapping layers of marginalization might shape and substantiate one another and affect the precision-medicine research cycle, and put forth strategies to facilitate equitable advantages from precision-medicine research to diverse participants and internally heterogeneous communities.

Citing Articles

Nothing about Us without Us in Precision Medicine: A Call to Reframe Disability Difference in Genetics and Genomics.

Mintz K, Stramondo J, Tabor H Hastings Cent Rep. 2024; 54 Suppl 2:S41-S48.

PMID: 39707943 PMC: 11665891. DOI: 10.1002/hast.4928.


The modern-day "Rest Cure": "The yellow Wallpaper" and underrepresentation in clinical research.

Villar C Philos Ethics Humanit Med. 2024; 19(1):8.

PMID: 38867305 PMC: 11170852. DOI: 10.1186/s13010-024-00158-8.


Intersectionality, Genetic Testing, and Intrafamilial Communication of Risk: A Qualitative Study.

Hesse-Biber S, Seven M, Shea H, Dwyer A Cancers (Basel). 2024; 16(9).

PMID: 38730719 PMC: 11083191. DOI: 10.3390/cancers16091766.

References
1.
Erickson C, Clark L, Umucu E, Vo N, Volgman A, Chin N . Cardiology clinic patient attitudes toward and potential personal utility of genetic testing: Findings from a unique multiracial clinical sample. J Genet Couns. 2022; 31(4):989-997. PMC: 9545732. DOI: 10.1002/jgc4.1573. View

2.
Theisen J, Amarillo I . Creating Affirmative and Inclusive Practices When Providing Genetic and Genomic Diagnostic and Research Services to Gender-Expansive and Transgender Patients. J Appl Lab Med. 2020; 6(1):142-154. DOI: 10.1093/jalm/jfaa165. View

3.
dAgincourt-Canning L, Baird P . Genetic testing for hereditary cancers: the impact of gender on interest, uptake and ethical considerations. Crit Rev Oncol Hematol. 2006; 58(2):114-23. DOI: 10.1016/j.critrevonc.2006.03.001. View

4.
Vears D, Minion J, Roberts S, Cummings J, Machirori M, Blell M . Return of individual research results from genomic research: A systematic review of stakeholder perspectives. PLoS One. 2021; 16(11):e0258646. PMC: 8575249. DOI: 10.1371/journal.pone.0258646. View

5.
Curtin M, Somayaji D, Dickerson S . Precision Medicine Testing and Disparities in Health Care for Individuals With Non-Small Cell Lung Cancer: A Narrative Review. Oncol Nurs Forum. 2022; 49(3):257-272. DOI: 10.1188/22.ONF.257-272. View